Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis.

Stavropoulos-Kalinoglou, A and Metsios, GS and Panoulas, VF and Nightingale, P and Koutedakis, Y and Kitas, GD (2012) Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis. Arthritis Research and Therapy, 14 (4). ISSN 1478-6354 DOI: https://doi.org/10.1186/ar3900

Abstract

More Information

Divisions: Carnegie > Sport
Identification Number: https://doi.org/10.1186/ar3900
Status: Published
Refereed: Yes
Publisher: BioMed Central
Uncontrolled Keywords: Humans; Arthritis, Rheumatoid; Insulin Resistance; Obesity; Body Weight; Tumor Necrosis Factor-alpha; Antirheumatic Agents; Aged; Middle Aged; Female; Male
Date Deposited: 05 Jul 2016 10:48
Last Modified: 05 Jul 2016 10:48
Item Type: Article

Download

[img]
Preview

Export Citation

Share

Statistics

Additional statistics for this record